BMYB34:BVMF
Bristol-Myers Squibb Company BDR
331,90 BRL
arrow_upward
+0,65%(+2,15) 1D
30 sht, 11:31:25 p.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për BMYB34...
Kapitalizimi i tregut
121,95 mld
Vëllimi mesatar
3,00
Vëllimi
0,00
Maksimumi 52-javor
347,15 BRL
Minimumi 52-javor
221,72 BRL
Aksionet në qarkullim
2,04 mld
Numri i punonjësve
32 mijë
Kapitalizimi i tregut
121,95 mld
Vëllimi mesatar
3,00
Vëllimi
0,00
Maksimumi 52-javor
347,15 BRL
Minimumi 52-javor
221,72 BRL
Aksionet në qarkullim
2,04 mld
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
3 orë më parë
Bristol Myers Squibb stock gains 0.55 percent after-hours to EUR 53.19
MarketBeat
·
4 orë më parë
MRA Advisory Group Reduces Holdings in Bristol Myers Squibb Company $BMY
Simply Wall Street
·
23 orë më parë
Bristol Myers Squibb (BMY) Expands CAMZYOS Approval, Is The Stock Still A Bargain?
MarketWatch
·
1 ditë më parë
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Profili
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Rreth Bristol-Myers Squibb Company BDR
Drejtori ekzekutivChris Boerner
Punonjësit32,5 mijë
Themeluar më1887
SeliaNew York City, New York, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtibms.com